Header image: Pixabay.com
All biotech firms depend on their intellectual property rights. Their IP rights, often patents, will either be a result of the firm’s own R&D or they may have been bought or licensed in from another party.
Patenting of biotech inventions offers special challenges, which require an updated knowledge on special patent case law in Europe. Plougmann Vingtoft has this knowledge and will help you through the process. You can contact one of our IPR experts listed below for more information on patenting of biotechnological inventions or fill outwith your enquiry and we will get back to you as soon as possible.